• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Coagulation Biomarkers for Predicting Clinical Outcomes Among Patients With Atrial Fibrillation: Piecing Together the Biomarkers.

作者信息

Choi Eue-Keun, Kwon Soonil

机构信息

Department of Internal Medicine, Seoul National University College of Medicine and Seoul National University Hospital, Seoul, Korea.

出版信息

JACC Asia. 2023 Aug 15;3(4):608-610. doi: 10.1016/j.jacasi.2023.07.002. eCollection 2023 Aug.

DOI:10.1016/j.jacasi.2023.07.002
PMID:37614537
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10442870/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/897b/10442870/52920a7f670c/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/897b/10442870/b21b4e035de7/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/897b/10442870/52920a7f670c/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/897b/10442870/b21b4e035de7/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/897b/10442870/52920a7f670c/gr1.jpg

相似文献

1
Coagulation Biomarkers for Predicting Clinical Outcomes Among Patients With Atrial Fibrillation: Piecing Together the Biomarkers.用于预测心房颤动患者临床结局的凝血生物标志物：整合生物标志物
JACC Asia. 2023 Aug 15;3(4):608-610. doi: 10.1016/j.jacasi.2023.07.002. eCollection 2023 Aug.
2
Coagulation Biomarkers and Clinical Outcomes in Elderly Patients With Nonvalvular Atrial Fibrillation: ANAFIE Subcohort Study.老年非瓣膜性心房颤动患者的凝血生物标志物与临床结局：ANAFIE亚组研究
JACC Asia. 2023 Aug 15;3(4):595-607. doi: 10.1016/j.jacasi.2023.06.004. eCollection 2023 Aug.
3
Evaluation of coagulation and fibrinolysis in horses with atrial fibrillation.心房颤动马匹凝血和纤溶功能的评估。
J Am Vet Med Assoc. 2016 Jan 15;248(2):201-6. doi: 10.2460/javma.248.2.201.
4
Effect of apixaban compared with warfarin on coagulation markers in atrial fibrillation.阿哌沙班对比华法林对房颤患者凝血标志物的影响。
Heart. 2019 Feb;105(3):235-242. doi: 10.1136/heartjnl-2018-313351. Epub 2018 Sep 12.
5
Assessment of trough rivaroxaban concentrations on markers of coagulation activation in nonvalvular atrial fibrillation population.评估非瓣膜性心房颤动人群中利伐沙班谷浓度对凝血激活标志物的影响。
Heart Vessels. 2017 May;32(5):609-617. doi: 10.1007/s00380-016-0912-0. Epub 2016 Oct 28.
6
Plasma D-dimer level is associated with clinical outcomes in patients with atrial fibrillation related acute ischemic stroke after pneumonia.血浆 D-二聚体水平与肺炎后伴心房颤动的急性缺血性脑卒中患者的临床结局相关。
BMC Neurol. 2021 Mar 27;21(1):137. doi: 10.1186/s12883-021-02168-x.
7
Coagulation markers and echocardiography predict atrial fibrillation, malignancy or recurrent stroke after cryptogenic stroke.凝血标志物和超声心动图可预测隐源性卒中后的心房颤动、恶性肿瘤或复发性卒中。
Medicine (Baltimore). 2018 Dec;97(51):e13830. doi: 10.1097/MD.0000000000013830.
8
Impact of different energy sources on coagulation biomarkers and silent cerebral events in balloon-based ablation for atrial fibrillation.不同能量源对基于球囊的房颤消融术中凝血生物标志物及无症状脑事件的影响。
Heart Rhythm O2. 2024 Jun 25;5(8):520-528. doi: 10.1016/j.hroo.2024.06.009. eCollection 2024 Aug.
9
A quantitative systems pharmacology model of blood coagulation network describes in vivo biomarker changes in non-bleeding subjects.一种凝血网络的定量系统药理学模型描述了非出血受试者体内生物标志物的变化。
J Thromb Haemost. 2016 Dec;14(12):2430-2445. doi: 10.1111/jth.13515.
10
Serum D-dimer Levels Are Proportionally Associated with Left Atrial Enlargement in Patients with an Acute Ischemic Stroke due to Non-valvular Atrial Fibrillation.在非瓣膜性心房颤动所致急性缺血性卒中患者中，血清D-二聚体水平与左心房扩大呈比例相关。
Intern Med. 2016;55(11):1447-52. doi: 10.2169/internalmedicine.55.6087. Epub 2016 Jun 1.

本文引用的文献

1
Coagulation Biomarkers and Clinical Outcomes in Elderly Patients With Nonvalvular Atrial Fibrillation: ANAFIE Subcohort Study.老年非瓣膜性心房颤动患者的凝血生物标志物与临床结局：ANAFIE亚组研究
JACC Asia. 2023 Aug 15;3(4):595-607. doi: 10.1016/j.jacasi.2023.06.004. eCollection 2023 Aug.
2
Validation of Biomarker-Based ABCD Score in Atrial Fibrillation Patients with a Non-Gender CHADS-VASc Score 0-1: A Korean Multi-Center Cohort.基于生物标志物的 ABCD 评分在非性别 CHADS2-VASc 评分 0-1 的心房颤动患者中的验证：一项韩国多中心队列研究。
Yonsei Med J. 2022 Oct;63(10):892-901. doi: 10.3349/ymj.2022.0157.
3
The association of coagulation and atrial fibrillation: a systematic review and meta-analysis.
凝血与心房颤动的关联：系统评价和荟萃分析。
Europace. 2023 Feb 8;25(1):28-39. doi: 10.1093/europace/euac130.
4
Predictive value of CHA2DS2-VASc score combined with hs-CRP for new-onset atrial fibrillation in elderly patients with acute myocardial infarction.CHA2DS2-VASc 评分联合 hs-CRP 对老年急性心肌梗死患者新发心房颤动的预测价值。
BMC Cardiovasc Disord. 2021 Apr 13;21(1):175. doi: 10.1186/s12872-021-01978-8.
5
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC.2020年欧洲心脏病学会（ESC）与欧洲心胸外科学会（EACTS）合作制定的心房颤动诊断和管理指南：欧洲心脏病学会（ESC）心房颤动诊断和管理特别工作组，由ESC欧洲心律协会（EHRA）特别贡献制定。
Eur Heart J. 2021 Feb 1;42(5):373-498. doi: 10.1093/eurheartj/ehaa612.
6
Identification of Markers Associated With Development of Stroke in "Clinically Low-Risk" Atrial Fibrillation Patients.识别与“临床低危”心房颤动患者中风发展相关的标志物。
J Am Heart Assoc. 2019 Nov 5;8(21):e012697. doi: 10.1161/JAHA.119.012697. Epub 2019 Oct 31.
7
Refining Stroke and Bleeding Prediction in Atrial Fibrillation by Adding Consecutive Biomarkers to Clinical Risk Scores.通过向临床风险评分中添加连续生物标志物来完善房颤患者的中风和出血预测。
Stroke. 2019 Jun;50(6):1372-1379. doi: 10.1161/STROKEAHA.118.024305. Epub 2019 May 14.
8
Long-term bleeding risk prediction in 'real world' patients with atrial fibrillation: Comparison of the HAS-BLED and ABC-Bleeding risk scores. The Murcia Atrial Fibrillation Project.“真实世界”中房颤患者的长期出血风险预测：HAS-BLED 和 ABC-Bleeding 风险评分的比较。穆尔西亚房颤项目。
Thromb Haemost. 2017 Oct 5;117(10):1848-1858. doi: 10.1160/TH17-07-0478. Epub 2017 Aug 11.
9
Repeated Measurements of Cardiac Biomarkers in Atrial Fibrillation and Validation of the ABC Stroke Score Over Time.心房颤动中心脏生物标志物的重复测量及ABC卒中评分随时间的验证。
J Am Heart Assoc. 2017 Jun 23;6(6):e004851. doi: 10.1161/JAHA.116.004851.
10
Reproducibility in biomarker research and clinical development: a global challenge.生物标志物研究与临床开发中的可重复性：一项全球挑战。
Biomark Med. 2017 Apr;11(4):309-312. doi: 10.2217/bmm-2017-0024. Epub 2017 Mar 14.